Translational Research in Malignancies Members
The Translational Research in Malignancies (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Dinner, Shira N
Associate Professor
Bio
Dr. Dinner is a clinical researcher with an interest in novel molecularly targeted therapies for leukemias, in particular acute lymphoblastic leukemia (ALL). Development of future clinical t... [more]
Dixit, Karan S
Assistant Professor
Bio
My research interests focus on primary brain tumors, specifically low grade gliomas, CNS lymphoma, and high grade gliomas. I also have an interest in integrating neuropsychological testing with advanc... [more]
Dmello, Crismita
Assistant Professor
Bio
My central hypothesis is that glioma cell-specific Chek2-YBX1/3 interaction transcriptionally reprograms the glioma cells to escape the CD8 T cell mediated killing.